drugset / Trial / NCT00433784
H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel
Phase 4
Completed
120 enrolled
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
RandomizedParallel-groupDouble-blindDiagnostic
Summary
The purpose of this study was to assess whether interpatient variability in the platelet response to clopidogrel is partly due to polymorphisms of the hepatic cytochrome P450 (CYP450)3A and of the clopidogrel-P2Y12 receptor genes.
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | — | — |